PA
QUAD icon

PharVision Advisers’s Quad QUAD Stock Holding History

PharVision Advisers’s Portfolio QUAD Stock Details QUAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
+21,901
New +$141K 1.47% 12
2025
Q4 		– Sell
-20,905
Closed -$131K – 948
2025
Q3 		$131K Buy
+20,905
New +$129K 0.07% 591
2025
Q1 		– Sell
-104,974
Closed -$732K – 474
2024
Q4 		$732K Buy
+104,974
New +$711K 0.62% 13

Other funds holding QUAD

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GVAG
Great Valley Advisor Group Wilmington, Delaware $5.5B AUM 20.56% 1-Year Est. Return

PharVision Advisers's QUAD Position: Q1 2026 in Review

PharVision Advisers opened a new position in Quad (QUAD) in Q1 2026: 21,901 shares worth $145K. The stake represents 1.47% of the portfolio and ranks #12 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in QUAD as recently as Q3 2025.

PharVision Advisers first reported a position in QUAD in Q4 2024 and has held it in 3 quarters since. The position peaked at $732K in Q4 2024. 150 funds tracked by Wall St. Rank hold QUAD as of Q1 2026.

  • PharVision Advisers held 21,901 shares of Quad worth $145K as of Q1 2026.
  • Quad was a new PharVision Advisers position in Q1 2026.
  • Quad made up 1.47% of PharVision Advisers's portfolio in Q1 2026, its #12 holding.
  • PharVision Advisers first reported a position in Quad in Q4 2024 and has held it in 3 quarters since.
  • PharVision Advisers's Quad position peaked at $732K in Q4 2024.
  • 150 funds tracked by Wall St. Rank held Quad as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.